Clinical Updates

The FDA has loosened restrictions on the diabetes drug rosiglitazone (Avandia) - under fire since 2007 because of potential cardiovascular… »   

A third agent that acts directly against hepatitis C (HCV) has been approved, according to the company that makes the… »   

Health regulators said on Monday they would lift restrictions on the use of GlaxoSmithKline Plc’s once widely prescribed diabetes drug… »   

Women using a popular acne drug that causes birth defects need better information about how to keep from getting pregnant,… »   

The U.S. Food and Drug Administration said on Friday it has expanded the approved use of the cancer drug… »   

Drugs that inhibit the activity of enzymes called histone deacetylases (HDACs) are being widely developed for treating cancer and other… »   

In the field of drug design, the protein K-Ras is legendary. It’s been on everyone’s “target” list for more than… »   

Amgen Inc’s experimental heart medicine from a closely watched new class of drugs called PCSK9 inhibitors lowered “bad” LDL cholesterol… »   

GlaxoSmithKline and Theravance’s new inhaled lung drug Relvar has been approved in Europe to treat both asthma and chronic obstructive… »   

Horizon Pharma Inc said it would buy the right to market AstraZeneca Plc’s arthritis drug Vimovo in the United… »   

Combining the drug gemtuzumab ozogamicin (GO) with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children… »   

U.S. health regulators on Wednesday approved a drug to treat a rare and aggressive form of non-Hodgkin lymphoma developed by… »   

An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in… »   

U.S. health regulators on Friday approved a new drug made by Sunovion Pharmaceuticals, a U.S.-based unit of Japanese drugmaker Dainippon… »   

The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with… »